141 related articles for article (PubMed ID: 12659890)
1. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
Banerjee R; Chakraborty H; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
[TBL] [Abstract][Full Text] [Related]
2. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
Chakraborty H; Roy S; Sarkar M
Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
Chakraborty H; Banerjee R; Sarkar M
Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
[TBL] [Abstract][Full Text] [Related]
4. Forced and long-term degradation assays of tenoxicam, piroxicam and meloxicam in river water. Degradation products and adsorption to sediment.
Jiménez JJ; Muñoz BE; Sánchez MI; Pardo R
Chemosphere; 2018 Jan; 191():903-910. PubMed ID: 29145135
[TBL] [Abstract][Full Text] [Related]
5. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
Mondal Roy S; Sarkar M
Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drug induced membrane fusion: concentration and temperature effects.
Mondal S; Sarkar M
J Phys Chem B; 2009 Dec; 113(51):16323-31. PubMed ID: 19954169
[TBL] [Abstract][Full Text] [Related]
7. The reactions of oxicam and sulfoanilide non steroidal anti-inflammatory drugs with hypochlorous acid: determination of the rate constants with an assay based on the competition with para-aminobenzoic acid chlorination and identification of some oxidation products.
Van Antwerpen P; Dubois J; Gelbcke M; Neve J
Free Radic Res; 2004 Mar; 38(3):251-8. PubMed ID: 15129733
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Oxicam NSAIDs with lipid monolayer: anomalous dependence on drug concentration.
Kundu S; Chakraborty H; Sarkar M; Datta A
Colloids Surf B Biointerfaces; 2009 Apr; 70(1):157-61. PubMed ID: 19157803
[TBL] [Abstract][Full Text] [Related]
9. Effects of non-steroid anti-inflammatory drugs in membrane bilayers.
Kyrikou I; Hadjikakou SK; Kovala-Demertzi D; Viras K; Mavromoustakos T
Chem Phys Lipids; 2004 Dec; 132(2):157-69. PubMed ID: 15555602
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
Chakraborty S; Bose M; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
[TBL] [Abstract][Full Text] [Related]
11. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
[TBL] [Abstract][Full Text] [Related]
12. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
Roy S; Banerjee R; Sarkar M
J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
[TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination for oxicam non-steroidal anti-inflammatory drugs in human serum by liquid chromatography-tandem mass spectrometry.
Shirako J; Kawasaki M; Komine K; Kunisue Y; Terada M; Sasaki C; Irie W; Murakami C; Tonooka K; Tomobe K; Shinozuka T
Forensic Sci Int; 2013 Apr; 227(1-3):100-2. PubMed ID: 23273940
[TBL] [Abstract][Full Text] [Related]
15. Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl).
Taha EA; Salama NN; Fattah Lel-S
Chem Pharm Bull (Tokyo); 2006 May; 54(5):653-8. PubMed ID: 16651760
[TBL] [Abstract][Full Text] [Related]
16. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex.
Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P
Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590
[TBL] [Abstract][Full Text] [Related]
17. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.
Alladi S; Shastri NR
Arch Pharm Res; 2015; 38(5):801-12. PubMed ID: 24752862
[TBL] [Abstract][Full Text] [Related]
18. Small Mismatches in Fatty Acyl Tail Lengths Can Effect Non Steroidal Anti-Inflammatory Drug Induced Membrane Fusion.
Majumdar A; Sarkar M
J Phys Chem B; 2016 Jun; 120(21):4791-802. PubMed ID: 27153337
[TBL] [Abstract][Full Text] [Related]
19. Interaction of piroxicam and meloxicam with DMPG/DMPC mixed vesicles: anomalous partitioning behavior.
Chakraborty H; Sarkar M
Biophys Chem; 2007 Feb; 125(2-3):306-13. PubMed ID: 17010502
[TBL] [Abstract][Full Text] [Related]
20. A new RP-HPLC method for analysis of meloxicam in tablets.
Arayne MS; Sultana N; Siddiqui FA
Pak J Pharm Sci; 2005 Jan; 18(1):58-62. PubMed ID: 16431386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
